Cell Biosciences Gets $10M
Palo Alto-based Cell Biosciences, a developer of instrumentation systems for the life science industry, announced Thursday that the firm has raised $10M in a Series C round. The round was led by the Wellcome Trust, and also included prior investors Domain Associates, Latterell Venture Partners, Novo A/S, Mitsui Ventures, Royal Bank of Canada and The Vertical Group. Cell Biosciences is developing a nanofluidic, immunoassay systems used to analyze proteins in very small biological samples.
posted on Thursday, April 9, 2009 (Link to more information)
Related companies:
Cell Biosciences
Related stories:
> Cell Biosciences Buys Alpha Innotech, Raises $19M
> Cell Biosciences Acquires Convergent Bioscience, Raises Funding
> Cell Biosciences Gets Funding
> Cell Biosciences Completes Acquisition of Alpha Innotech
> Cell Biosciences Acquires Canadian Firm
silicontap.com Home